CHAL 25 |
| In this presentation, an approach to developing a counterfeit identification program will be described which is applicable to any pharmaceutical product. The focus of this presentation is the description of an approach to developing a counterfeit identification program which is applicable to any pharmaceutical product. The steps which comprise this development process and the rationale behind each step will be presented. The advantages of using a multi-disciplinary approach to develop the program will also be discussed. |
|
Brand Protection and Counterfeit Identification in the Pharmaceutical Industry
1:30 PM-3:30 PM, Tuesday, April 8, 2008 Morial Convention Center -- Rm. 243, Oral
Division of Chemistry & the Law |